The FDA has approved a new four-dose, single-patient-use KwikPen for Zepbound (tirzepatide), giving patients a full month of treatment in one device.

Moderator and TBJ reporter Lilly Egan (left to right), and Mentoring Monday 2026 panelists Jennifer Borrero, Dean of Students at Salem College, Emily Edwards, Chief Digital & Marketing Officer for ...

Novo Nordisk will set a $675/month US list price (effective January 1, 2027) for Wegovy, Ozempic, and Rybelsus, targeting affordability for high-deductible and coinsurance designs. Impacted doses ...

Lilly Larson could have quit gymnastics a long time ago. It would be understandable — she lives an hour away from the nearest gym. "Jamestown is an hour from where I live, but it was the only option ...

International Equities added another 5% in the fourth quarter, finishing up over 30% for the year, the largest gain since ...

Most veteran investors can attest that, although they're also often a complete bust, every now and then a biopharma stock ...

The SANFL’s new breed of female football talent is about to take centre stage, with a host of future stars lining up in the ...

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly ...

The combination of AstraZeneca's Calquence and AbbVie/Roche's Venclexta has become the first all-oral, fixed-duration regimen for patients with newly-diagnosed chronic lymphocytic leukaemia (CLL) in ...

Adults with obesity may now move directly from Wegovy 2.4mg to 7.2mg if they need greater weight loss ...

Beatrice Vos, Celine Halioua, Laura Gustafson, and Fabian Kausche recognized for leadership, innovation and mentorship ...

Q4 2025 Earnings Call February 19, 2026 8:00 AM ESTCompany ParticipantsBen Vallejo - Investor Relations DirectorJason Wells ...